oxymatrine has been researched along with palmitic acid in 1 studies
| Studies (oxymatrine) | Trials (oxymatrine) | Recent Studies (post-2010) (oxymatrine) | Studies (palmitic acid) | Trials (palmitic acid) | Recent Studies (post-2010) (palmitic acid) |
|---|---|---|---|---|---|
| 412 | 16 | 270 | 6,794 | 159 | 2,458 |
| Protein | Taxonomy | oxymatrine (IC50) | palmitic acid (IC50) |
|---|---|---|---|
| Toll-like receptor 2 | Homo sapiens (human) | 5 | |
| Fatty acid-binding protein, intestinal | Homo sapiens (human) | 1.7 | |
| Fatty acid-binding protein, adipocyte | Homo sapiens (human) | 0.93 | |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 8.8 | |
| Fatty acid-binding protein 5 | Homo sapiens (human) | 1.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Huang, W; Li, Y; Ren, L; Song, G; Wang, Y; Yang, L; Zhang, H | 1 |
1 other study(ies) available for oxymatrine and palmitic acid
| Article | Year |
|---|---|
Oxymatrine alleviated hepatic lipid metabolism via regulating miR-182 in non-alcoholic fatty liver disease.
Topics: Alkaloids; Animals; Body Weight; Diet, High-Fat; Gene Knockdown Techniques; Hep G2 Cells; Humans; Insulin Resistance; Lipid Metabolism; Liver; Male; MicroRNAs; Non-alcoholic Fatty Liver Disease; Palmitic Acid; Quinolizines; Rats; Rats, Wistar | 2020 |